Testing effectiveness (Phase 2)Ended earlyNCT02401061What this trial is testingPRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITPWho this might be right forImmune Thrombocytopenia Protalex, Inc. 13
Not applicableUnknownNCT04735588What this trial is testingInvestigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITPWho this might be right forImmune ThrombocytopeniaITPCovid19+1 more Gruppo Italiano Malattie EMatologiche dell'Adulto 140
Not applicableLooking for participantsNCT07205861What this trial is testingRetrospective Epidemiological Study of Patients in the National Cohort of the French TMA CenterWho this might be right forThrombotic Thrombocytopenic Purpura (TTP)Immune Thrombotic Thrombocytopenic PurpuraThrombotic Microangiopathies+5 more Assistance Publique - Hôpitaux de Paris 1,200
Large-scale testing (Phase 3)Study completedNCT03164915What this trial is testingA Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia SK Plasma Co., Ltd. 37
Testing effectiveness (Phase 2)Looking for participantsNCT07362238What this trial is testingDaratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune ThrombocytopeniaTreatment Institute of Hematology & Blood Diseases Hospital, China 122
Large-scale testing (Phase 3)Looking for participantsNCT07194850What this trial is testingEfgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia (ITP)ITP - Immune ThrombocytopeniaITP+4 more argenx 24
Large-scale testing (Phase 3)Study completedNCT02279173What this trial is testingLong-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Amgen 203
Early research (Phase 1)Not Yet RecruitingNCT07622329What this trial is testingA Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune ThrombocytopeniaWho this might be right forThrombocytopenic Purpura, Immune The General Hospital of Western Theater Command 4
Post-approval studies (Phase 4)Study completedNCT01957176What this trial is testingA Rollover Study to Provide Continued Treatment With EltrombopagWho this might be right forThrombocytopaenia Novartis Pharmaceuticals 22
Not applicableActive Not RecruitingNCT05046717What this trial is testingImprovement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic PurpuraWho this might be right forAcquired Thrombotic Thrombocytopenic Purpura Fundación Española de Hematología y Hemoterapía 500
Testing effectiveness (Phase 2)UnknownNCT05943691What this trial is testingHigh-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized TrialWho this might be right forITP - Immune Thrombocytopenia Shandong University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023915What this trial is testingRandomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITPWho this might be right forImmune Thrombocytopenia Shandong University 106
Not applicableApproved For MarketingNCT04247906What this trial is testingSingle Patient Expanded Access Treatment Plan For The Investigational Product NarsoplimabWho this might be right forHematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA) Omeros Corporation
Testing effectiveness (Phase 2)Study completedNCT00625443What this trial is testingPhase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003Who this might be right forIdiopathic Thrombocytopenic Purpura Eisai Inc. 53
Post-approval studies (Phase 4)Study completedNCT01390649What this trial is testingA Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)Who this might be right forImmune Thrombocytopenic Purpura CSL Behring 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07057778What this trial is testingIguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITPWho this might be right forImmune Thrombocytopenia (ITP) Peking University People's Hospital 120
Large-scale testing (Phase 3)Study completedNCT02063789What this trial is testingAn Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Green Cross Corporation 81
Large-scale testing (Phase 3)Not Yet RecruitingNCT07051915What this trial is testingThe Holistic StudyWho this might be right forThrombocytopenia Purpura Ostfold Hospital Trust 220
Testing effectiveness (Phase 2)Study completedNCT01713738What this trial is testingClinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)Who this might be right forIdiopathic Thrombocytopenic Purpura (ITP)Immune Thrombocytopenic Purpura (ITP) Neufeld, Ellis J, MD, PhD 36
Testing effectiveness (Phase 2)Ended earlyNCT01129024What this trial is testingAn Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Shionogi 19